Print this chapterPrint this chapter

Unit 2 - Global health governance and Big Pharma in the age of crisis

Core Reading List

Additional readings


  1. Benvenisti, E. (2020) The WHO – Destined to fail? Political cooperation and the Covid-19 pandemic. The American Society of International Law, 114(4): 588-597.
  2. Boffey, D. (2020) Exclusive: big pharma rejected EU plan to fast-track vaccines in 2017. The Guardian. Available at: https://www.theguardian.com/world/2020/may/25/exclusive-big-pharma-rejected-eu-plan-to-fast-track-vaccines-in-2017 (link)
  3. Bollyky, T.J. and Brown, C.P. (2020) The Tragedy of Vaccine Nationalism. Only Cooperation Can End the Pandemic. Foreign Affairs, September/October 2020. Available at: https://www.foreignaffairs.com/articles/united-states/2020-07-27/vaccine-nationalism-pandemic (link)
  4. Callaway, E. (2020) The unequal scramble for coronavirus vaccines - by the numbers. Nature 584(7822): 506-507. Available at: https://www.nature.com/articles/d41586-020-02450-x (link)
  5. Dunford, M. and Qi, B. (2020) Global reset: COVID-19, systemic rivalry and the global order. Research in Globalization, 2: 1-12. Available at: https://www.researchgate.net/publication/343474595_Global_reset_COVID-19_systemic_rivalry_and_the_global_order (link)
  6. Elbe, S., Roemer-Mahler, A. and Long, C. (2015) Medical countermeasures for national security: A new government role in the pharmaceuticalization of society. Social Science & Medicine, 131: 263-271. Available at: https://www.sciencedirect.com/science/article/pii/S0277953614002664?via%3Dihub (link)
  7. Kremer, M. (2002) Pharmaceuticals and the developing world. Journal of Economic Perspectives, 16(4): 67-90. Available at: https://www.aeaweb.org/articles?id=10.1257/089533002320950984 (link)

  8. Mazzucato, M., Li, H.L. and Darzi, A. (2020) Is it time to nationalise the pharmaceutical industry? British Medical Journal, 769. Available at: https://heatinformatics.com/sites/default/files/images-videosFileContent/bmj.m769.full_.pdf (link)

  9. Roemer-Mahler, A. (2014) The rise of companies from emerging markets in global health governance: Opportunities and challenges. Review of International Studies, (2014), 40: 897–918. Available at: https://www.cambridge.org/core/journals/review-of-international-studies/article/rise-of-companies-from-emerging-markets-in-global-health-governance-opportunities-and-challenges/D3E562B5E7196322AB329709499B3E56# (link)

  10. Wallace, R., Liebman, A. Chaves, L. F. and Wallace, R. (2020) COVID-19 and Circuits of Capital: New York to China and Back, Monthly Review, 1-15. https://monthlyreview.org/2020/05/01/covid-19-and-circuits-of-capital/ (link)